Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

digestive system neuroendocrine tumor, grade 1/2 - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

digestive system neuroendocrine tumor, grade 1/2

MONDO:0000386

Also known as:alimentary part of gastrointestinal system neuroendocrine tumoralimentary part of gastrointestinal system neuroendocrine tumourdigestive system NET

Find Clinical TrialsTrials

Overview

A well-differentiated neuroendocrine tumor arising from the digestive system. It is characterized by the presence of cells with features similar to those of the normal endocrine cells of the digestive system. The neoplastic cells express immunohistochemical evidence of neuroendocrine differentiation and hormones. There is mild to moderate nuclear atypia and less than 20 mitoses per 10 HPF. It includes well-differentiated endocrine tumors or carcinoid tumors and well-differentiated endocrine carcinomas.

Clinical Trials39 registered · 12 recruiting

Diagnosis

Biomarker and diagnostic research for digestive system neuroendocrine tumor, grade 1/2 has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

39 clinical trials registered, 12 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and medical devices. Pipeline includes 2 PHASE4, 7 PHASE3, 9 PHASE2. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT07165132](https://clinicaltrials.gov/study/NCT07165132)

Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:56 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 39 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Research summaries	39	26%
Clinical study results	37	25%
Disease patterns and progression	24	16%
Testing and diagnosis research	23	16%
Laboratory research	14	9%
New treatment approaches	6	4%
Other research	4	3%
Patient case studies	1	1%

digestive system neuroendocrine tumor, grade 1/2

Overview

Diagnosis

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications